Table 4.
Endpoint | Group | Models | AUC (95% CI) | p value | Accuracy (%) | Sensitivity (%) | Specificity (%) |
---|---|---|---|---|---|---|---|
3-Year CSS | Training | Clinical model | 0.839 (0.735–0.914) | < 0.001 | 78.4 | 70.5 | 90.0 |
Radiomic model | 0.886 (0.790–0.948) | < 0.001 | 81.1 | 90.0 | 77.3 | ||
Combined model | 0.914 (0.825–0.966) | < 0.001 | 86.5 | 96.7 | 79.5 | ||
Validation | Clinical model | 0.757 (0.580–0.887) | 0.005 | 73.5 | 78.6 | 70.0 | |
Radiomic model | 0.818 (0.648–0.929) | < 0.001 | 76.5 | 100.0 | 60.0 | ||
Combined model | 0.843 (0.677–0.944) | < 0.001 | 79.4 | 85.7 | 75.0 |
The criterion values recommended by the MedCalc software for accuracy calculation for the clinical, radiomic, and combined model were 0.2865, 0.3324, and 0.2737 in the training group and 0.3625, 0.2101, and 0.4332 in the validation group, respectively
CSS cancer-specific survival